Methylcrotonoyl-CoA carboxylase subunit alpha is an enzyme that in humans is encoded by the MCCC1 gene.

MCCC1
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesMCCC1, MCC-B, MCCA, methylcrotonoyl-CoA carboxylase 1, methylcrotonyl-CoA carboxylase subunit 1, MCCCalpha
External IDsOMIM: 609010; MGI: 1919289; HomoloGene: 10603; GeneCards: MCCC1; OMA:MCCC1 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001293273
NM_020166
NM_001363880

NM_023644

RefSeq (protein)

NP_001280202
NP_064551
NP_001350809

NP_076133

Location (UCSC)Chr 3: 183.02 – 183.12 MbChr 3: 36.01 – 36.05 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Function

edit

MCCC1 encodes the α-subunit of the mitochondrial enzyme methylcrotonyl-CoA carboxylase (MCC), which catalyzes a key carboxylation step in the catabolic pathway of the branched-chain amino acid leucine. The MCC holoenzyme forms a dodecameric α6β6 complex in which MCCC1-derived α subunits contain the biotin-binding and carboxylation domains essential for enzymatic activity.[5]

Clinical significance

edit

Pathogenic variants in MCCC1 cause 3-methylcrotonyl-CoA carboxylase deficiency, an autosomal recessive metabolic disorder characterized by impaired leucine degradation and accumulation of organic acid intermediates.[6][7]

Beyond its metabolic role, MCCC1 has been implicated in immune regulation, where it enhances antiviral signaling through MAVS-mediated activation of NF-κB and interferon pathways,[8] and in neurodegenerative disease genetics, with intronic variants such as rs12637471 associated with altered gene expression and Parkinson’s disease susceptibility.[9]

References

edit
  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000078070 Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000027709 Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. "MCCC1 gene". MedlinePlus Genetics. U.S. National Library of Medicine, National Institutes of Health. March 7, 2024. Retrieved October 20, 2025.
  6. Baumgartner MR, Almashanu S, Suormala T, Obie C, Cole RN, Packman S, et al. (February 2001). "The molecular basis of human 3-methylcrotonyl-CoA carboxylase deficiency". The Journal of Clinical Investigation. 107 (4): 495–504. doi:10.1172/JCI11948. PMC 199271. PMID 11181649.
  7. Grünert SC, Stucki M, Morscher RJ, Suormala T, Bürer C, Burda P, et al. (May 2012). "3-methylcrotonyl-CoA carboxylase deficiency: clinical, biochemical, enzymatic and molecular studies in 88 individuals". Orphanet Journal of Rare Diseases. 7 31. doi:10.1186/1750-1172-7-31. PMC 3495011. PMID 22642865.
  8. Cao Z, Xia Z, Zhou Y, Yang X, Hao H, Peng N, et al. (September 2016). "Methylcrotonoyl-CoA carboxylase 1 potentiates RLR-induced NF-κB signaling by targeting MAVS complex". Scientific Reports. 6 33557. Bibcode:2016NatSR...633557C. doi:10.1038/srep33557. PMC 5024325. PMID 27629939.
  9. Sogabe S, Nakano H, Ogasahara Y, Cha PC, Ando Y, Taniguchi-Ikeda M, et al. (July 2025). "Regulation of MCCC1 expression by a Parkinson's disease-associated intronic variant: implications for pathogenesis". Journal of Human Genetics. 70 (7): 371–374. doi:10.1038/s10038-025-01335-z. PMC 12137145. PMID 40216992.